Abbott Labs (ABT)

Abbott Labs was granted 510(k) clearance by the FDA for an antibody cyclic-citrulinated peptide, or anti-CCP assay, to run on its ARCHITECT immunoassay analyzers.
Many patients with RA develop an immune response against proteins containing citrulline long before they present symptoms of the disease. Studies show detecting the level of these antibodies earlier in the disease continuum, in conjunction with other clinical information, is critical to the early diagnosis of the disease.

Oct 20 · 12:25:00 PM · Source: Reuters
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto